Statement of Income (Statement) - USD ($) shares in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Income Statement [Abstract] | ||||
| Revenue | $ 31,341,000 | $ 32,027,000 | $ 61,034,000 | $ 64,328,000 |
| Operating expenses: | ||||
| Cost of revenue | 6,299,000 | 5,114,000 | 11,058,000 | 10,480,000 |
| Product development | 2,932,000 | 3,138,000 | 6,013,000 | 6,980,000 |
| Sales and marketing | 9,259,000 | 10,546,000 | 18,251,000 | 21,669,000 |
| General and administrative | 6,286,000 | 6,517,000 | 13,051,000 | 13,714,000 |
| Depreciation on continuing operations | 2,450,000 | 3,761,000 | 5,247,000 | 7,745,000 |
| Amortization | 303,000 | 0 | 538,000 | 0 |
| Restructuring | 0 | 4,216,000 | 0 | 6,486,000 |
| Impairment of goodwill | 0 | 0 | 0 | 7,800,000 |
| Total operating expenses | 27,529,000 | 33,292,000 | 54,158,000 | 74,874,000 |
| Operating income (loss) | 3,812,000 | (1,265,000) | 6,876,000 | (10,546,000) |
| Interest expense and other | 687,000 | 619,000 | 1,240,000 | 1,279,000 |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount | (17,000) | (37,000) | (40,000) | 27,000 |
| Income (loss) before income taxes | 3,108,000 | (1,921,000) | 5,596,000 | (11,798,000) |
| Income tax expense (benefit) | 511,000 | (1,080,000) | 1,467,000 | (1,206,000) |
| Net income (loss) | $ 2,597,000 | $ (841,000) | $ 4,129,000 | $ (10,592,000) |
| Basic earnings (loss) per share (in dollars per share) | $ 0.06 | $ (0.02) | $ 0.10 | $ (0.23) |
| Diluted earnings (loss) per share (in dollars per share) | $ 0.06 | $ (0.02) | $ 0.10 | $ (0.23) |
| Weighted average basic shares outstanding | 40,604 | 45,354 | 41,009 | 45,429 |
| Weighted average diluted shares outstanding | 42,093 | 45,354 | 42,218 | 45,429 |
| X | ||||||||||
- Definition Depreciation on continuing operations No definition available.
|
| X | ||||||||||
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of impairment loss on investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|